Back to Search
Start Over
Medical anticancer treatment of lung cancer associated with comorbidities: a review.
- Source :
-
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2015 Mar; Vol. 87 (3), pp. 241-8. Date of Electronic Publication: 2015 Jan 16. - Publication Year :
- 2015
-
Abstract
- Comorbidities are frequent in patients with lung cancer, who are often treated with systemic anticancer therapy. The purpose of the present review is to report the adaptations recommended for the various drugs used in lung cancer treatment, in the context of a specific comorbidity. The literature was reviewed for neurologic, endocrine, hepatic, renal, digestive, cardiovascular, pulmonary, blood and systemic diseases. The comorbidities impact on the systemic anticancer treatment is poorly assessed. There are no good data with a high level of evidence and literature is often limited to experts' opinion and to case reports. We need to improve our knowledge about those patients by adequate multicentric and prospective studies and registries in order to offer them better care in term of evidence-based medicine.<br /> (Copyright © 2015. Published by Elsevier Ireland Ltd.)
- Subjects :
- Cardiovascular Diseases complications
Digestive System Diseases complications
Endocrine System Diseases complications
Hematologic Diseases complications
Humans
Kidney Diseases complications
Liver Diseases complications
Lung Diseases complications
Nervous System Diseases complications
Comorbidity
Lung Neoplasms complications
Lung Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1872-8332
- Volume :
- 87
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Lung cancer (Amsterdam, Netherlands)
- Publication Type :
- Academic Journal
- Accession number :
- 25617984
- Full Text :
- https://doi.org/10.1016/j.lungcan.2015.01.007